ICAAC, 53rd (2013)

Title Content type
Isavuconazole Protects Immunosuppressed Mice from Rhizopus oryzae Infection (click for details)
Comparative Effects on Candida albicans Cell Wall Chitin Content and Antifungal Activity of Triazoles and Amphotericin B (click for details)
No Effect on Pharmacokinetic and Pharmacodynamic Parameters of Warfarin after Coadministration with Isavuconazole (click for details)
Efficacy of Antifungal Therapy with Inhaled Itraconazole against Murine Invasive Pulmonary Aspergillosis with Itraconazole-Low Susceptible Aspergillus fumigatus (click for details)
Detailed Antifungal Stewardship (AFS) is Key to Achieving Excellent Plasma Levels During Oral Posaconazole (PCZ) Prophylaxis in High Risk Hematology Patients (click for details)
Pharmacodynamics (PD) of Isavuconazole (Isav) in a Murine Invasive Pulmonary Aspergillosis (IPA) Model Against Wildtype (WT) and Cyp51 mutants (click for details)
Posaconazole Prophylaxis in Experimental Azole-resistant Invasive Pulmonary Aspergillosis (click for details)
Tissue Cytokine Levels and Histopathology Following Liposomal Amphotericin B (LA) or Caspofungin (C) Treatment of Echinocandin Resistant (ER) or Sensitive (ES) Candida glabrata (Cg) Infection (click for details)
Comparison of CLSI and EUCAST Antifungal Susceptibility Profile with Therapeutic Outcome in HIV-positive Cryptococcosis Patients Due to Cryptococcus neoformans var. grubii in India (click for details)
Epidemiology of Candidemia in a Spanish Tertiary Hospital: Identification and Molecular Mechanisms of Resistance (click for details)

Pages

Subscribe to ICAAC, 53rd (2013)